2898 — Sunho Biologics Share Price
0.000.00%
Last trade - 00:00HealthcareMid Cap
- HK$6.58bn
- HK$6.56bn
- CNY56.13m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 468.58 | ||
| Price to Tang. Book | 468.58 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 112.5 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -372.86% | ||
| Return on Equity | -135.13% | ||
| Operating Margin | -89.87% | ||
Financial Summary
| Year End 31st Mar | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 123.69 | 81.67 | 94.82 | 57.12 | 56.13 | n/a | n/a | -23.74% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Sunho Biologics Inc is a company mainly engaged in the research, development and production of biotechnology. The Company is primarily engaged in the discovery, development and commercialization of biologics that modulate the immune microenvironment by directly modulating the innate and adaptive immune systems. The Company has three core products, namely IAH0968, IAP0971 and IAE0972. IAH0968 is an antibody-dependent cell-mediated cytotoxicity-enhancing monoclonal antibody. IAP0971 and IAE0972 are both antibody cytokines.
Directors
- Last Annual
- March 31st, 2021
- Last Interim
- March 31st, 2021
- Incorporated
- May 14th, 2021
- Public Since
- May 24th, 2024
- No. of Employees
- 130
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 156,666,800
- Address
- Room 302, Building 3, HUZHOU
- Web
- http://www.sunho-bio.com.cn/
- Phone
- Auditors
- Deloitte Touche Tohmatsu
Upcoming Events for 2898
Similar to 2898
Abbisko Cayman
Stock Exchange of Hong Kong Limited
Akeso
Stock Exchange of Hong Kong Limited
Alphamab Oncology
Stock Exchange of Hong Kong Limited
Antengene
Stock Exchange of Hong Kong Limited
Ascentage Pharma International
Stock Exchange of Hong Kong Limited
FAQ
What is the Sunho Biologics share price?
As of Today at 23:29 UTC, shares in Sunho Biologics are trading at HK$4.35. This share price information is delayed by 15 minutes.
How has the Sunho Biologics share price performed this year?
Shares in Sunho Biologics last closed at HK$4.35 and the price had moved by +1044.74% over the past 365 days. In terms of relative price strength the Sunho Biologics share price has outperformed the FTSE Developed Asia Pacific Index by +1057.81% over the past year.
What are the analyst and broker recommendations for Sunho Biologics?
There is no consensus recommendation for this security.
Find out moreWhat is the Sunho Biologics dividend yield?
Sunho Biologics does not currently pay a dividend.
Does Sunho Biologics pay a dividend?
Sunho Biologics does not currently pay a dividend.
When does Sunho Biologics next pay dividends?
Sunho Biologics does not currently pay a dividend.
How do I buy Sunho Biologics shares?
To buy shares in Sunho Biologics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Sunho Biologics?
As of the previous close price of HK$4.35, shares in Sunho Biologics had a market capitalisation of HK$6.58bn.
Where are Sunho Biologics shares listed?
Here are the trading details for Sunho Biologics:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 2898
What kind of share is Sunho Biologics?
Based on an overall assessment of its quality, value and momentum Sunho Biologics is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Sunho Biologics share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Sunho Biologics share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Sunho Biologics. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -16.19%.
As of the last closing price of HK$4.35, shares in Sunho Biologics were trading -13.02% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Sunho Biologics PE Ratio?
The Sunho Biologics PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$4.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Sunho Biologics?
We do not have data on Sunho Biologics' directors